Cancer
JACKSONVILLE, Fla. — Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1[...]
Latest stories
Research
January 30, 2026
Research
January 29, 2026
Research
January 28, 2026
Research
January 28, 2026
Research
January 22, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community